Critical assessment of new devices

Hamilton, Carole
May 2007
Perfusion;May2007, Vol. 22 Issue 3, p167
Academic Journal
The article presents information related to the assessment of safety standards of medical devices. Medical devices are grouped into four product classes on the basis of potential risks associated with the use of them. The Medical Device Directives (MDD) of Great Britain analyze safety and risk associated with the medical products.


Related Articles

  • Medical device amendments don't preempt state tort claims. Snapp, Kevin // Defense Counsel Journal;Oct96, Vol. 63 Issue 4, p549 

    Reports on the US Supreme Court ruling regarding the alleged preemption of state-law tort claims against medical device manufacturers by the Medical Device Amendments of 1976 to the Federal Food, Drug and Cosmetic Act. Filing of suit against Medtronic Inc. by customer Lora Lohr; Stating of law...

  • Shaping Up China's Medical Device Industry. Yang, Chen // China Business Review;May/Jun2008, Vol. 35 Issue 3, p24 

    The article discusses the state of drug and medical device industry in China. Spurred by several shocking incidents related to the quality of these devices produced in the country, the author stresses that China needs a more complete regulatory framework for medical devices to ensure product...

  • FDA to Cardiac Science Corp.: "Ensure quality of external heart defibrillators".  // Fire Engineering;Oct2006, Vol. 159 Issue 10, p50 

    The article reports on the violations uncovered by the U.S. Federal Food and Drug Administration (FDA) on its inspection with the Deerfield, Wisconsin plant of Cardiac Science Corp. The company's violations include the failure to maintain procedures in taking corrective actions when flaws are...

  • Recall of A&A medical devices.  // Contemporary OB/GYN;Jun2002, Vol. 47 Issue 6, p26 

    Reports on the recall of sterile medical devices and products manufactured since 1999 by A&A Medical Inc., according to a statement by the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health in 2002. Reasons behind the product recall; Web site of the FDA; Contact...

  • Sulzer lays it all on the table to settle suits. Bradford, Michael // Business Insurance;8/27/2001, Vol. 35 Issue 35, p4 

    Reports on the willingness of United States-based Sulzer Orthopedics Inc., maker of artificial hip and knee joints, to settle lawsuits filed by patients who claim they were injured by the company's products. Settlement proposal; Lawsuits against Sulzer.

  • FDA's New: Postmarket Safety Programme. King, Lisa // Medical Device Technology;Mar2006, Vol. 17 Issue 2, p62 

    The article outlines the initiatives of the newly launched program, Postmarket Safety Programme, by the U.S. Food and Drug Administration's Center for Devices and Radiological Health. The program aims to transform and improve its ability to oversee the safety of medical devices marketed in the...

  • An Engineer's Role in Preparing for FDA Inspections. Covino, Joan M. // Biomedical Instrumentation & Technology;Nov/Dec2005, Vol. 39 Issue 6, p459 

    Examines the role of engineers in preparing for inspections by the U.S. Food and Drug Administration (FDA). Approach of FDA to evaluate quality management systems (QMS); Considerations to meet QMS requirements; Activity requirements of medical device manufacturers; Basic rules of FDA inspection...

  • DEVISING NEW TACTICS. Mantone, Joseph // Modern Healthcare;5/8/2006, Vol. 36 Issue 19, p24 

    The article focuses on the efforts of health care providers and medical device manufacturers to address product recalls in the industry. The lack of an efficient recall notification system in Johns Hopkins Health System has led to the death of two of its patients. The Heart Rhythm Society has...

  • Managing Clinical Data For Worldwide Acceptance. Donawa, Maria // Medical Device Technology;Oct2006, Vol. 17 Issue 8, p26 

    Manufacturers conducting clinical studies to support medical device safety and performance claims need to ensure that clinical study data are appropriately managed. Not doing so can risk the success of the project related to the clinical study. This article discusses a guideline that can assist...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics